output_id | display_id | version | name | displayTitle | sectionType | order | subSection_id | subSection_text | subSectionId |
---|
Out14-1 | Disp14-1-1 | 1 | Demog-M | Summary of Demographics (Male) | Title | 2 | Disp14-1-1GlobalDisp_Title_1Out14-12 | Summary of Demographics |
Disp14-1-1 | 1 | Demographics - Male | A summary of demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for male subjects | Demog-M | Summary of Demographics (Male) | Title | 23 | Disp14-1-1_Title_1 | Table 14.1.1 | 3 | Male SubjectsOut14-1 |
Disp14-1-1 | 1 | DemogDemographics - MMaleSummary | A summary of Demographics (Male) | Title | 3 | Disp14-1-1_Title_2 | Summary of Demographics | Out14-1 | Disp14-1-1 | 1demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for male subjects | Demog-M | Summary of Demographics (Male) | TitleFooter | 41 | Disp14-1-1_Title_3 | Male Subjects | Out14-1 | Disp14-1-1 | Footer_1 | Source dataset: adsl, Generated on: DDMONYYYY:HH:MM |
Disp14-1-1 | 1 | Demographics - Male | A summary of demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for male subjects1 | Demog-M | Summary of Demographics (Male) | FootnoteRowlabel Header | 1 | Disp14-1-1_FnoteRLbHd_1 | Source dataset: adsl, Generated on: DDMONYYYY:HH:MM | Out14-1 | Disp14-1-1 | 1 | Characteristics |
Disp14-1-2 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Demog-FDemog-M | Summary of Demographics (MaleFemale) | Rowlabel Header | 1Disp14 | -1-1_RLbHdGlobalDisp_Header_1 | Characteristics | Out14-1Study CDISCPILOT01 |
Disp14-1-2 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Demog-F | Summary of Demographics (Female) | Title | 1 | GlobalDispDisp14-1-2_Title_1Out14-1 | Table 14.1.2 |
Disp14-1-2 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Demog-F | Summary of Demographics (Female) | Title | 2 | Disp14-1-21_Title_1Table 14.1.2Out14-1 | Summary of Demographics |
Disp14-1-21 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Demog-F | Summary of Demographics (Female) | Title | 3 | Disp14-1-12_Title_2Out14-1 | Female Subjects |
Disp14-1-21 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Demog-F | Summary of Demographics (Female) | TitleFooter | 41 | Disp14-1-21_TitleFooter_2 | Female Subjects | Out14-11 | Source dataset: adsl, Generated on: DDMONYYYY:HH:MM |
Disp14-1-2 | 1Demog-F | Summary of Demographics (- Female) | Footnote | 1 | Disp14-1-1_Fnote_1 | | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Out14-1 | Disp14-1-2 | 1 | Demog-F | Summary of Demographics (Female) | Rowlabel Header | 1 | Disp14-1-1_RLbHd_1 | Characteristics |
Out14Disp14-3-1-1 | 1 | Disp14-3-1-1 | 1 | | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | TitleHeader | 1 | GlobalDisp_TitleHeader_1 | Study CDISCPILOT01 |
Out14Disp14-3-1-1 | 1-1 | Disp14-3-1-1 | 1 | | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Title | 21 | Disp14-3-1-1_Title_1 | Table 14.3.1.1 |
Out14Disp14-3-1-1 | 1-1 | Disp14-3-1-1 | 1 | | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Title | 32 | Disp14-3-1-1_Title_2 | Overall Summary of Treatment-Emergent Adverse Events |
Out14Disp14-3-1-1-1 | Disp14-3-1-1 | 1 | 1 | 1 | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Abbreviation | 1 | Disp14-3-1-1_Abbrv_1 | Note: TEAE=Treatment-Emergent Adverse Events. |
Out14Disp14-3-1-1 | 1-1 | Disp14-3-1-1 | 1 | | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Footnote | 1 | Disp14-3-1-1_Fnote_1 | [a] Dose Modification includes Dose Reduced; Drug Interrupted in the AE action taken with study treatment. |
Out14Disp14-3-1-1 | 1 | Disp14-3-1-1 | 1 | | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | FootnoteFooter | 21 | Disp14-3-1-1_FnoteFooter_21 | Source dataset: adae, Generated on: DDMONYYYY:HH:MM |
Out14Disp14-3-1-1 | 1 | Disp14-3-1-1 | 1 | | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Rowlabel Header | 1 | Disp14-3-1-1_RLbHd_1 | Categories, n (%) |